Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

DenmarkBack to Denmark

Clinical trials in Roskilde – page 57

1 178 clinical trials in Roskilde, Denmark across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Roskilde at a glance
1 178
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

1 178 trials in Roskilde

Open in trial search

Chronic kidney disease

Not recruiting

Study of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Pulmonary arterial hypertension

Not recruiting

Study of Sotatercept for Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension Patients

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Sotatercept
  • Sponsor:Acceleron Pharma Inc.

Haemophilia

Not recruiting

Study of Long-term Safety and Efficacy of Fitusiran in Patients with Hemophilia A or B with or without Inhibitory Antibodies to Factor VIII or IX

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Fitusiran
  • Sponsor:Genzyme Corp.

Glioblastoma

Not recruiting

Phase 1b Study of CC-90010 with Temozolomide in Adults with Newly Diagnosed Glioblastoma After Surgery

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Temozolomide
  • Sponsor:Celgene Corp.

Type 1 diabetes mellitus+2

Not recruiting

Efficacy and Safety of Tirzepatide Versus Placebo in Adults with Type 1 Diabetes and Obesity or Overweight: A Phase 3 Randomized Controlled Trial

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Tirzepatide
  • Sponsor:Eli Lilly & Co.

Hereditary ataxia

Not recruiting

Safety and tolerability of intrathecal S233107 in participants with spinocerebellar ataxia type 3: a Phase 1b/2a first‑in‑human randomized study

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:S233107
  • Sponsor:Institut De Recherches Internationales Servier IRIS

Non-small cell lung cancer

Not recruiting

Continuation study of JDQ443 in patients with KRAS G12C‑mutated non‑small cell lung cancer receiving JDQ443 as monotherapy or drug combination

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Cetuximab
  • Sponsor:Novartis Pharma AG

Chronic rhinosinusitis with nasal polyps

Not recruiting

Long‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Obesity

Not recruiting

A study to evaluate the efficacy and safety of zenagamtide in people with obesity

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Zenagamtide
  • Sponsor:Novo Nordisk A/S

Infertility male

Not recruiting

A study to evaluate the use of leflutrozole to improve semen quality in men with non-obstructive azoospermia

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · Healthy volunteers
  • Substances:Leflutrozole
  • Sponsor:Region Hovedstaden

Small cell lung cancer extensive stage

Not recruiting

Study of tarlatamab and durvalumab compared to durvalumab alone for patients with extensive stage small cell lung cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Argipressin
  • Sponsor:Amgen Inc.

Herpes zoster

Not recruiting

Evaluating the effect of recombinant varicella zoster virus glycoprotein E vaccine on heart problems and dementia in adults aged 65 years or older with herpes zoster

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:65+ years · Healthy volunteers
  • Sponsor:Gentofte Hospital

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Roskilde

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on endometrial carcinoma, non-small cell lung cancer, and chronic myeloid leukemia treatments. Studies evaluate novel therapeutic combinations and targeted approaches for better patient outcomes.

  • Advanced cancer therapies
  • Immunotherapy combinations
  • Molecular response studies

Ongoing investigations into personalized treatment approaches for various cancer types.

02 Cardiovascular Studies

Research focusing on heart failure prevention and cardiovascular disease management. Studies evaluate new treatments and combinations like baxdrostat with dapagliflozin.

  • Prevention strategies
  • Risk reduction therapies
  • Innovative drug combinations

Comprehensive trials aimed at improving cardiovascular outcomes in high-risk populations.

03 Immunology and Dermatology

Clinical investigations into atopic dermatitis, plaque psoriasis, and hidradenitis suppurativa. Evaluating new therapeutic options for chronic inflammatory conditions.

  • Inflammatory skin conditions
  • Novel biological therapies
  • Treatment efficacy studies

Advancing treatment options for patients with moderate to severe skin conditions.

04 Infectious Disease Research

Studies focusing on meningococcal immunization and viral infections. Investigating vaccine safety and efficacy in different age groups, from infants to adults.

  • Vaccine development
  • Immunogenicity studies
  • Prevention strategies

Important research advancing preventive medicine and infection control.

Back to DenmarkAll countries
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.